Biology of cholesteatoma: Special considerations in pediatric patients

International Journal of Pediatric Otorhinolaryngology

Volumn 76, Issue 3, 2012, Pages 319-321

  Preciado, Diego A ^a  

^a GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

Author keywords

Cholesteatoma; Keratinocyte proliferation; NF kappaB; Pediatric; Pro inflammation

Indexed keywords

CELL MIGRATION; CELL PROLIFERATION; CHILD; CHOLESTEATOMA; HUMAN; KERATINOCYTE; MASTOID; MIDDLE EAR; PATHOGENESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; SQUAMOUS EPITHELIUM; TEMPORAL BONE TUMOR; TUMOR CLASSIFICATION;

ADULT; AGE FACTORS; CHILD; CHOLESTEATOMA, MIDDLE EAR; HUMANS;

EID: 84856785103     PISSN: 01655876     EISSN: 18728464     Source Type: Journal    
DOI: 10.1016/j.ijporl.2011.12.014     Document Type: Review

References (39)

1. Albino A.P., Kimmelman C.P., Parisier S.C. Cholesteatoma: a molecular and cellular puzzle. Am. J. Otol. 1998, 19:7-19.
2. Derlacki E.L., Clemis J.D. Congenital cholesteatoma of the middle ear and mastoid. Ann. Otol. Rhinol. Laryngol. 1965, 74:706-727.
3. Michaels L. An epidermoid formation in the developing middle ear: possible source of cholesteatoma. J. Otolaryngol. 1986, 15:169-174.
4. Friedberg J. Congenital cholesteatoma. Laryngoscope 1994, 104:1-24.
5. Karmody C.S., Byahatti S.V., Blevins N., Valtonen H., Northrop C. The origin of congenital cholesteatoma. Am. J. Otol. 1998, 19:292-297.
6. Potsic W.P., Samadi D.S., Marsh R.R., Wetmore R.F. A staging system for congenital cholesteatoma. Arch. Otolaryngol. Head Neck Surg. 2002, 128:1009-1012.
7. Kim Y.H., Yoo J.C., Lee J.H., et al. Stage progression of congenital cholesteatoma in children. Eur. Arch. Otorhinolaryngol. 2011.
8. Palva T. The pathogenesis and treatment of cholesteatoma. Acta Otolaryngol. 1990, 109:323-330.
9. Ruedi L. Cholesteatoma formation in the middle ear in animal experiments. Acta Otolaryngol. 1959, 50:233-240. (discussion 40-42).
10. Tos M. Incidence, etiology and pathogenesis of cholesteatoma in children. Adv. Otorhinolaryngol. 1988, 40:110-117.
11. Tos M., Poulsen G. Attic retractions following secretory otitis. Acta Otolaryngol. 1980, 89:479-486.
12. Michaels L. Biology of cholesteatoma. Otolaryngol. Clin. North Am. 1989, 22:869-881.
13. Freedberg I.M., Tomic-Canic M., Komine M., Blumenberg M. Keratins and the keratinocyte activation cycle. J. Invest. Dermatol. 2001, 116:633-640.
14. Kojima H., Tanaka Y., Tanaka T., et al. Cell proliferation and apoptosis in human middle ear cholesteatoma. Arch. Otolaryngol. Head Neck Surg. 1998, 124:261-264.
15. Alves A.L., Pereira C.S., Carvalho M.D., Fregnani J.H., Ribeiro F.Q. EGFR expression in acquired middle ear cholesteatoma in children and adults. Eur. J. Pediatr. 2011.
16. Baeuerle P.A., Henkel T. Function and activation of NF-kappa B in the immune system. Annu. Rev. Immunol. 1994, 12:141-179.
17. Beg A.A., Finco T.S., Nantermet P.V., Baldwin A.S. Tumor necrosis factor and interleukin-1 lead to phosphorylation and loss of I kappa B alpha: a mechanism for NF-kappa B activation. Mol. Cell. Biol. 1993, 13:3301-3310.
18. Cavaillon J.M., Haeffner-Cavaillon N. Signals involved in interleukin 1 synthesis and release by lipopolysaccharide-stimulated monocytes/macrophages. Cytokine 1990, 2:313-329.
19. Libermann T.A., Baltimore D. Activation of interleukin-6 gene expression through the NF-kappa B transcription factor. Mol. Cell. Biol. 1990, 10:2327-2334.
20. Ergun S., Zheng X., Carlsoo B. Expression of transforming growth factor-alpha and epidermal growth factor receptor in middle ear cholesteatoma. Am. J. Otol. 1996, 17:393-396.
21. Bujia J., Kim C., Holly A., Sudhoff H., Ostos P., Kastenbauer E. Epidermal growth factor receptor (EGF-R) in human middle ear cholesteatoma: an analysis of protein production and gene expression. Am. J. Otol. 1996, 17:203-206.
22. Ondrey F.G., Juhn S.K., Adams G.L. Early-response cytokine expression in adult middle ear effusions. Otolaryngol. Head Neck Surg. 1998, 119:342-345.
23. Guttridge D.C., Albanese C., Reuther J.Y., Pestell R.G., Baldwin A.S. NF-kappaB controls cell growth and differentiation through transcriptional regulation of cyclin D1. Mol. Cell. Biol. 1999, 19:5785-5799.
24. Hinz M., Krappmann D., Eichten A., Heder A., Scheidereit C., Strauss M. NF-kappaB function in growth control: regulation of cyclin D1 expression and G0/G1-to-S-phase transition. Mol. Cell. Biol. 1999, 19:2690-2698.
25. Preciado D., Caicedo E., Jhanjee R., et al. Pseudomonas aeruginosa lipopolysaccharide induction of keratinocyte proliferation, NF-kappa B, and cyclin D1 is inhibited by indomethacin. J. Immunol. 2005, 174:2964-2973.
26. Hamajima Y., Komori M., Preciado D.A. The role of inhibitor of DNA-binding (Id1) in hyperproliferation of keratinocytes: the pathological basis for middle ear cholesteatoma from chronic otitis media. Cell. Prolif. 2010, 43:457-463.
27. Zhang Q.A., Hamajima Y., Zhang Q., Lin J. Identification of Id1 in acquired middle ear cholesteatoma. Arch. Otolaryngol. Head Neck Surg. 2008, 134:306-310.
28. Glasscock M.E., Dickins J.R., Wiet R. Cholesteatoma in children. Laryngoscope 1981, 91:1743-1753.
29. Charachon R., Eyraud S., Guenoun A., Egal F. Surgical treatment of cholesteatoma in children. Rev. Laryngol. Otol. Rhinol. (Bord.) 1984, 105:465-474.
30. Sanna M., Zini C., Gamoletti R., et al. The surgical management of childhood cholesteatoma. J. Laryngol. Otol. 1987, 101:1221-1226.
31. Palva A., Karma P., Karja J. Cholesteatoma in children. Arch. Otolaryngol. 1977, 103:74-77.
32. Bujia J., Holly A., Antoli-Candela F., Tapia M.G., Kastenbauer E. Immunobiological peculiarities of cholesteatoma in children: quantification of epithelial proliferation by MIB1. Laryngoscope 1996, 106:865-868.
33. Dornelles Cde C., da Costa S.S., Meurer L., Rosito L.P., da Silva A.R., Alves S.L. Comparison of acquired cholesteatoma between pediatric and adult patients. Eur. Arch. Otorhinolaryngol. 2009, 266:1553-1561.
34. Vercruysse J.P., De Foer B., Somers T., Casselman J.W., Offeciers E. Mastoid and epitympanic bony obliteration in pediatric cholesteatoma. Otol. Neurotol. 2008, 29:953-960.
35. Stankovic M. Follow-up of cholesteatoma surgery: open versus closed tympanoplasty. ORL. J. Otorhinolaryngol. Relat. Spec. 2007, 69:299-305.
36. Chadha N.K., Jardine A., Owens D., Gillett S., Robinson P.J., Maw A.R. A multivariate analysis of the factors predicting hearing outcome after surgery for cholesteatoma in children. J. Laryngol. Otol. 2006, 120:908-913.
37. Shirazi M.A., Muzaffar K., Leonetti J.P., Marzo S. Surgical treatment of pediatric cholesteatomas. Laryngoscope 2006, 116:1603-1607.
38. Sheehy J.L. Cholesteatoma surgery in children. Am. J. Otol. 1985, 6:170-172.
39. Schuring A.G., Lippy W.H., Rizer F.M., Schuring L.T. Staging for cholesteatoma in the child, adolescent, and adult. Ann. Otol. Rhinol. Laryngol. 1990, 99:256-260.